Identity
Verify who is requesting access and who they represent.
Additional framing: Credentialing to support bold and beneficial missions. Credentialing that safely unlocks your scientific good.
BioTrust helps AI labs, AI-bio tool developers, and gene synthesis providers make rapid, high-confidence access decisions. Legitimate research can move faster without lowering the bar for safety.
Sentinel Bio supports BioTrust’s work to build trusted-access infrastructure for powerful biological capabilities. Read the grant profile (opens in a new tab)
Applicants provide consistent information about identity, organization, and intended use.
Automation and expert review assemble evidence against a clear approval policy.
Providers receive a timely determination with reasoning appropriate to the case.
See it in action
Apply to join our pilotVerify who is requesting access and who they represent.
Understand the work, intended outcomes, and requested capabilities.
Review relevant experience, practices, and history.
Evaluate how sensitive tools, data, and outputs are protected.
Build a corroborated picture from credible external signals.
Check sanctions exposure and assess the jurisdictions relevant to the application.
Automated research gathers and structures evidence consistently across every application.
Experts investigate ambiguous or higher-risk cases where context changes the answer.
Providers receive a policy-aligned recommendation backed by traceable evidence and reasoning.
Talk with our team about your access policy, user population, and integration path.
Request a demoHelp build the trusted-access layer for frontier biological capabilities.
View open roles
Jonas Sandbrink signed the June 2026 letter alongside the CEOs of OpenAI, Anthropic, and Google DeepMind.

Jonas Sandbrink spoke at the Bipartisan Commission on Biodefense meeting on AI and the biological threat.
Jonas Sandbrink spoke on the panel ‘Synthesis Screening in the Age of Powerful AI.’